Letter

CAM

What to do about CAM?

BMJ 2007; 335 doi: 10.1136/bmj.39360.446528.BE (Published 11 October 2007)
Cite this as: BMJ 2007;335:736.2

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. David Colquhoun, professor of pharmacology
  1. University College London, London WC1E 6BT
  1. d.colquhoun@ucl.ac.uk

    Doug Kamerow seems excessively tolerant of people who make lots of money out of unproved and disproved treatments.1

    I prefer the straight talking of his compatriot, Gerald Weissmann, “If the trend persists, perhaps MIT [Massachusetts …

    Access to the full text of this article requires a subscription or payment

    Subscribe

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    Rapid responses

    THIS WEEK'S POLL

    BMJ most popular